Publications by authors named "Cynthia Cherry"

Claim this Profile
A
Association of Extended Dosing Intervals or Delays in Pembrolizumab-based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer.
Kartik Sehgal, Anushi Bulumulle, Heather Brody, Ritu R Gill, Shravanti Macherla, Cynthia R Cherry

Clin Lung Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting.
Melissa Y Y Moey, Anna N Tomdio, Justin D McCallen, Lauren M Vaughan, Kevin O'Brien, Cynthia Cherry

JACC CardioOncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, Vaia Florou, Yukihiro Toi, Cynthia Cherry

Cancer Immunol Immunother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Abdul Rafeh Naqash, Biagio Ricciuti, Dwight H Owen, Vaia Florou, Yukihiro Toi, Cynthia Cherry

Cancer Immunol Immunother· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
Chipman Rg Stroud, Aparna Hegde, Cynthia Cherry, Abdul R Naqash, Nitika Sharma

J Oncol Pharm Pract· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database.
Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Muhammad Umer Butt, Grace K Dy, Aparna Hegde, Cynthia R Cherry

Acta Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis